Thymic carcinoma staging: Difference between revisions
Jump to navigation
Jump to search
Marjan Khan (talk | contribs) |
Marjan Khan (talk | contribs) No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Thymic carcinoma}} | {{Thymic carcinoma}} | ||
{{CMG}}; {{AE}}{{ | {{CMG}}; {{AE}}{{Marjan}} | ||
==Overview== | ==Overview== | ||
The staging of thymic carcinoma is based on the Masoka and GETT staging system.<ref name="pmid8043287">{{cite journal| author=Masaoka A, Yamakawa Y, Niwa H, Fukai I, Saito Y, Tokudome S et al.| title=Thymectomy and malignancy. | journal=Eur J Cardiothorac Surg | year= 1994 | volume= 8 | issue= 5 | pages= 251-3 | pmid=8043287 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8043287 }} </ref> | The staging of thymic carcinoma is based on the Masoka and GETT staging system.<ref name="pmid8043287">{{cite journal| author=Masaoka A, Yamakawa Y, Niwa H, Fukai I, Saito Y, Tokudome S et al.| title=Thymectomy and malignancy. | journal=Eur J Cardiothorac Surg | year= 1994 | volume= 8 | issue= 5 | pages= 251-3 | pmid=8043287 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8043287 }} </ref> | ||
Line 12: | Line 12: | ||
*Stage I - Macroscopically and microscopically completely encapsulated | *Stage I - Macroscopically and microscopically completely encapsulated | ||
*Stage II - Macroscopic invasion into surrounding the [[adipose tissue]] or [[mediastinal]] [[pleura]] or microscopic invasion into the [[capsule]] | *Stage II - Macroscopic invasion into surrounding the [[adipose tissue]] or [[mediastinal]] [[pleura]] or microscopic invasion into the [[capsule]] | ||
*Stage III - Macroscopic invasion into adjacent organs or intrathoracic metastases | |||
*Stage IVA - Pleural or [[pericardial]] implants/dissemination | |||
*Stage IVB - Nodal or hematogenous metastases | |||
==GETT Staging System== | ==GETT Staging System== |
Latest revision as of 21:58, 25 July 2019
Thymic Carcinoma Microchapters |
Diagnosis |
---|
Case Studies |
Thymic carcinoma staging On the Web |
American Roentgen Ray Society Images of Thymic carcinoma staging |
Risk calculators and risk factors for Thymic carcinoma staging |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marjan Khan M.B.B.S.[2]
Overview
The staging of thymic carcinoma is based on the Masoka and GETT staging system.[1]
Masaoka TNM Staging System (1999)
Original Masaoka Staging System (1991)
- Stage I - Macroscopically and microscopically completely encapsulated
- Stage II - Macroscopic invasion into surrounding the adipose tissue or mediastinal pleura or microscopic invasion into the capsule
- Stage III - Macroscopic invasion into adjacent organs or intrathoracic metastases
- Stage IVA - Pleural or pericardial implants/dissemination
- Stage IVB - Nodal or hematogenous metastases
GETT Staging System
- Stage IA - Encapsulated, completely resected
- Stage IB - Macroscopically completely resected but suspicion of mediastinal adhesions or potential capsular invasion at surgery
- Stage II - Invasive tumor, completely resected
- Stage IIIA - Invasive tumor, subtotal resection
- Stage IIIB - Invasive tumor, biopsy alone
- Stage IVa - Supraclav or pleural met
- Stage IVb - Distant metastases
References
- ↑ Masaoka A, Yamakawa Y, Niwa H, Fukai I, Saito Y, Tokudome S; et al. (1994). "Thymectomy and malignancy". Eur J Cardiothorac Surg. 8 (5): 251–3. PMID 8043287.